Patents by Inventor Christian Dinter

Christian Dinter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline potassium salt of lipoxin Aanalogs
    Patent number: 8049035
    Abstract: This invention is directed to the crystalline potassium salt of a lipoxin A4 analog of Formula (I): processes for preparing the crystalline potassium salts, methods for using them to treat disease-states characterized by inflammation, and pharmaceutical compositions comprising such crystalline potassium salts.
    Type: Grant
    Filed: February 7, 2011
    Date of Patent: November 1, 2011
    Assignee: Bayer Pharma AG
    Inventors: Tilo Haag, Danja Grossbach, Gabriele Winter, Michael Sander, Wolfgang Beckmann, Klaus Bartel, Christian Dinter
  • CRYSTALLINE POTASSIUM SALT OF LIPOXIN A4 ANALOGS
    Publication number: 20110124910
    Abstract: This invention is directed to the crystalline potassium salt of a lipoxin A4 analog of Formula (I): processes for preparing the crystalline potassium salts, methods for using them to treat disease-states characterized by inflammation, and pharmaceutical compositions comprising such crystalline potassium salts.
    Type: Application
    Filed: February 7, 2011
    Publication date: May 26, 2011
    Inventors: Tilo HAAG, Danja Grossbach, Gabriele Winter, Michael Sander, Wolfgang Beckmann, Klaus Bartel, Christian Dinter
  • Crystalline potassium salt of lipoxin A4 analogs
    Patent number: 7906678
    Abstract: This invention is directed to the crystalline potassium salt of a lipoxin A4 analog of Formula (I): processes for preparing the crystalline potassium salts, methods for using them to treat disease-states characterized by inflammation, and pharmaceutical compositions comprising such crystalline potassium salts.
    Type: Grant
    Filed: December 3, 2007
    Date of Patent: March 15, 2011
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Tilo Haag, Danja Grossbach, Gabriele Winter, Michael Sander, Wolfgang Beckmann, Klaus Bartel, Christian Dinter
  • Process for preparing Estrogen-antagonistic 11 beta-Fluoro-17alpha-alkylestra-1,3,5(10)-triene-3,17-diols having a 7alpha-(xi-Alkylamino-omega-perfluoroalkyl)alkyl side chain and alpha-Alkyl(amino)-omega-perfluoro(alkyl)alkanes and Processes for their Preparation
    Publication number: 20090062558
    Abstract: The present invention relates to a new process for preparing estrogen-antagonistic 11?-fluoro-17?-alkylestra-1,3,5(10)-triene-3,17-diols of the general formula I having a 7?-(?-alkylamino-?-perfluoroalkyl)alkyl side chain and to ?-alkyl(amino)-?-perfluoro(alkyl)alkanes of the general formula II, to processes for their preparation and to the intermediates required for this purpose.
    Type: Application
    Filed: August 29, 2008
    Publication date: March 5, 2009
    Inventors: Michael SANDER, Danja Grossbach, Christian Dinter, Jorma Hassfeld, David Voigtlaender
  • 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
    Patent number: 7417056
    Abstract: Compounds of general formula (IIa) or (IIb) and their use as pharmaceutical agents.
    Type: Grant
    Filed: November 14, 2005
    Date of Patent: August 26, 2008
    Assignee: Schering AG
    Inventors: Stefan Jaroch, Hartmut Rehwinkel, Heike Schaecke, Norbert Schmees, Werner Skuballa, Jan Huebner, Orlin Petrov, Matthias Schneider, Christian Dinter
  • Crystalline potassium salt of lipoxin A4 analogs
    Publication number: 20080182897
    Abstract: This invention is directed to the crystalline potassium salt of a lipoxin A4 analog of Formula (I): processes for preparing the crystalline potassium salts, methods for using them to treat disease-states characterized by inflammation, and pharmaceutical compositions comprising such crystalline potassium salts.
    Type: Application
    Filed: December 3, 2007
    Publication date: July 31, 2008
    Applicant: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Tilo Haag, Danja Grossbach, Gabriele Winter, Michael Sander, Wolfgang Beckmann, Klaus Bartel, Christian Dinter
  • 5-Substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
    Publication number: 20060116396
    Abstract: Compounds of general formula (IIa) or (IIb) and their use as pharmaceutical agents.
    Type: Application
    Filed: November 14, 2005
    Publication date: June 1, 2006
    Inventors: Stefan Jaroch, Hartmut Rehwinkel, Heike Schaecke, Norbert Schmees, Werner Skuballa, Jan Huebner, Orlin Petrov, Matthias Schneider, Christian Dinter
  • Polymeric homogeneous catalysts
    Patent number: 6403522
    Abstract: A homogenous catalyst is prepared by reacting a ruthenium or molybdenum carbene catalyst of formula (I): in a non-reactive organic solvent or solvent mixture with a bicyclic olefin of formula (II): wherein X is O, NR1, C(R1)2, S, POR6, or PR6; R1 and R2 independently of each other, are H, (C1-C8)-alkyl, (C2-C8)-alkenyl, (C2-C8)-alkynyl, (C6-C18)-aryl, (C7-C19)-aralkyl, (C3-C18)-heteroaryl, (C4-C19)-heteroaralkyl, (C3-C8)-cycloalkyl, (C3-C8)-cycloalkenyl, (C6-C18)-aryl-(C1-C8)-alkyl, (C3-C18)-heteroaryl-(C1-C8)-alkyl, (C3-C8) -cycloalkyl-(C1-C8)-alkyl, or (C1-C8)-alkyl-(C3-C8)-cycloalkyl, or form together an ═O group; R3 and R4, independently of each other are OR1, SR1, NR12, OR7, SR7, or NR1R7 provided that at least one residue R3 or R4 bears a group R7, R6 is R1, provided that R6 is not H; R7 is a catalytically active group, and optionally with a further olefinic compound (III).
    Type: Grant
    Filed: April 21, 2000
    Date of Patent: June 11, 2002
    Assignee: Degussa AG
    Inventors: Carsten Bolm, Joerg Brozio, Christian Dinter, Hartwig Hoecker, Andreas Seger